Rebecca L. O'Brien, PhD Ask a Question Refer Patient Rebecca L. O'Brien, PhD, is a researcher at National Jewish Health. Dr. O'Brien is in the Department of Biomedical Research. Professor Department of Biomedical Research 5280 Top Doctors 2019 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2018-2019 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2019 — Castle Connolly Medical, Ltd. Email Profile Print Profile × No Rating Available In order to provide the most accurate and useful information on our providers, we only post satisfaction data when a provider has received a minimum of 30 survey responses. We have not yet received the minimum number of surveys for this provider, or this provider is a researcher who only sees a limited number of patients in clinic. To learn more about this survey, visit our about the Press Ganey Survey page. Close Overview Contact Info & Locations Research Areas Autoimmunity/Rheumatology Infectious Diseases Inflammation Special Interests Research Interets My research concerns the specificity and function of the gamma delta T lymphocytes. These cells represent a relatively rare type of T cell in mice and humans whose purpose is at this time not clear. Other lymphocytes, alpha beta T cells and B lymphocytes, by virtue of their antigen receptors, can detect and eliminate foreign micro-organisms from the body. The gamma delta T cells also carry T cell receptors (TCRs), related to but distinct from those carried by alpha beta T cells. However, instead of recognizing foreign molecules, gamma delta TCRs at least in some cases recognize molecules that are produced by our own bodies, which are induced during infection or inflammation and may be present on tumor cells. Different gamma delta T cell subsets appear to play distinct roles. These subsets are often defined by the expression in their TCR of particular Vgammas or Vgamma/Vdelta combinations. Projects are currently underway to further define the functional roles of several distinct mouse gamma delta T cell subsets during disease, two of which we have recently shown are potent producers of IL-17, a cytokine that is critically important in clearing infectious bacteria but which also can promote autoimmune damage. In addition, we recently discovered that female mice having particular genetic background, which cannot produce gamma? delta T cells, develop a severe inflammation of the cornea with high incidence. Investigation of how gamma delta T cells normally suppress this autoimmune attack on the eye is now in progress. Finally, we are attempting to discover the ligands for the TCRs expressed by certain gamma delta T cell subsets. This is critical not only to understanding how these cells function, but may also be key to manipulating gamma/delta T cells for use therapeutically. Here, we have generated multimeric versions of recombinant soluble gamma? delta TCRs, which can be used like monoclonal antibodies as reagents to detect their own ligands. The ligands appear to be cell surface molecules which are either themselves proteins or are protein-associated. We are now further defining which cells normally express these ligands, and what induces their expression. As well, work towards the purification and identification of natural ligands of gamma delta TCRs is underway. Education Education 1986 University of Washington, PhD 1982 University of Washington, MS 1979 Boise State University, BS Fellowship 1986 - 1989 National Jewish Health, Awards & Recognition 2008-Present: Member, Advisory Board, Faculty of 1000 2004-2008: NIH Study Section AITRC, regular member 2000: Harmon Award for Outstanding Research (Arthritis Foundation, Rocky Mountain Chapter) 1999: Schwartz-Weinstein Research Grant (Arthritis Foundation, Rocky Mountain Chapter) Publications O'Brien, R.L., Roark, C.L., Born, W.K. IL-17-producing gamma? delta T cells. Eur. J. Immunol. 39: 662-666, 2009 (ViewPoints article). French, J.D., Roark, C.L., Born, W.K., and O'Brien, R.L. gamma delta T lymphocyte homeostasis is negatively regulated by beta 2-microglobulin. J. Immunol.182: 1892-1900, 2009 (featured in, “In this issue”). Aydintug, M.K., Roark, C.L., Chain, J.L., Born, W.K., and O’Brien, R.L. Macrophages express several inducible ligands for gamma delta TCRs. Mol. Immunol. 45: 3253-3263, 2008. Roark, C.L., French, J.D. , Taylor, M.A., Bendele, A.M., Born, W.K., and O’Brien, R.L. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J. Immunol. 179: 5576-5583, 2007. French, J.D., Roark, C.L., Born, W.K., and O'Brien, R.L. gamma delta T cell homeostasis is established in competition with alpha beta T cells and NK cells. Proc. Natl. Acad. Sci. USA 102: 14741–14746, 2005. Academic Affiliations Professor, Department of Immunology & Microbiology, University of Colorado Denver Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 877.225.5654Fax: 303.398.1396 Locations National Jewish Health Main Campus 1400 Jackson St. Denver, CO 80206 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.